Related Experiment Video
Updated: Jun 8, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system
1Serviço de Medicina Interna, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, EPE, Lisboa, Portugal. pmarques.silva@sapo.pt
Abstract:
There is a body of evidence that supports the important role of the renin-angiotensin system (RAS) in atherosclerotic disease and in the cardiovascular disease continuum: from endothelial dysfunction to vascular occlusion. In the earlier stages of vascular disease, the RAS promotes functional changes, of which endothelial dysfunction is the best example. The deposition of atherogenic lipoproteins in the intima, their oxidative modification and the onset and amplification of the inflammatory response strengthens the atherogenic role of the RAS. Inflammatory cells are one of the main sources of angiotensin-converting enzyme (ACE) and angiotensin II (Ang II) in the vascular wall, in a process that leads to structural changes in the artery and progression of atherosclerotic disease. Ang II promotes the migration of vascular smooth muscle cells and their phenotypic differentiation in synthesis that accelerates vascular disease. By modulating the inflammatory response and, in general, all the elements of the plaque, Ang II plays a part in its instability, in the onset of acute events and in the promotion of the local prothrombotic state that leads to infarction.
Insights
The renin-angiotensin system (RAS) significantly contributes to atherosclerosis by promoting endothelial dysfunction and inflammation. Angiotensin II (Ang II) drives plaque progression, instability, and thrombotic events, impacting cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Vascular Biology
- Renal Physiology
Background:
- The renin-angiotensin system (RAS) plays a critical role in cardiovascular homeostasis.
- Evidence links RAS activity to the development and progression of atherosclerotic disease.
- Key components include angiotensin-converting enzyme (ACE) and angiotensin II (Ang II).
Purpose of the Study:
- To elucidate the multifaceted role of the RAS in the pathogenesis of atherosclerosis.
- To detail the mechanisms by which RAS components influence vascular dysfunction and plaque development.
- To highlight the impact of Ang II on inflammatory responses and plaque stability.
Main Methods:
- Review of existing scientific literature on RAS and atherosclerosis.
- Analysis of studies investigating endothelial function and vascular inflammation.
- Examination of research on Ang II's effects on vascular smooth muscle cells and plaque components.
Main Results:
- RAS activation promotes endothelial dysfunction, an early marker of vascular disease.
- Inflammatory cells contribute ACE and Ang II to the vascular wall, driving atherosclerotic progression.
- Ang II stimulates vascular smooth muscle cell migration and phenotypic changes, accelerating disease.
- Ang II modulates inflammatory responses, influencing plaque instability and thrombotic events.
Conclusions:
- The RAS is a key mediator in the continuum of cardiovascular disease, particularly in atherosclerosis.
- Ang II is a central player, promoting vascular damage, inflammation, plaque progression, and acute ischemic events.
- Targeting the RAS may offer therapeutic strategies for managing atherosclerotic and cardiovascular diseases.
Related Concept Videos
Hypertension II: Pathophysiology
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hormonal Regulation
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure II: Pathophysiology

